Timothyr Gershon News Today

A new study by researchers at the UNC Lineberger Comprehensive Cancer Center demonstrates that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.

The novel combination of two nanoparticle-formulated drugs has shown to extend the survival of mice with medulloblastoma

CHAPEL HILL, NC—UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.

Researchers from the Lineberger Comprehensive Cancer Center of the University of North Carolina (UNC) have shown that a unique combination of two drugs that serve as targeted inhibitors, supplied in a nanoparticle formulation, prolong the survival of mice with medulloblastoma.